Kristopher Lin

Kris & Hassan cycles London 2 Paris Fundraising for Cure Leukaemia

Fundraising for Cure Leukaemia
£2,609
raised of £3,000 target
Donations cannot currently be made to this page
Event: London 2 Paris, from 6 June 2024 to 10 June 2024
London 2 Paris 2024
Campaign by Cure Leukaemia (RCN 1100154)
Cure Leukaemia's London 2 Paris returns in 2024 for the best four days you can possibly spend on a bike!

Story

Help Us Cure Leukaemia - London to Paris Bike Ride!

Support us on a 500km journey from London to Paris as part of a wider PwC team, spanning over 4 days, raising funds to fight leukaemia.

Leukaemia devastates lives, tearing families apart. But together, we can make a difference. By supporting Cure Leukaemia, we fund groundbreaking research, innovative treatments, and life-saving clinical trials.

This challenging ride will push our limits as we conquer 3700m of elevation gain. Every pedal stroke brings us closer to a cure. Your support, big or small, directly impacts the lives of those affected. Let's create a world where leukaemia is just a memory.

Join us in this fight. Together, we can make a lasting impact.

Donate now and help us cure leukaemia!

Share this story

Help Kristopher Lin

Sharing this page with your friends could help raise up to 3x more in donations

You can also help by sharing this link on

About the campaign

Cure Leukaemia's London 2 Paris returns in 2024 for the best four days you can possibly spend on a bike!

About the charity

Cure Leukaemia

Verified by JustGiving

RCN 1100154
With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses at UK blood cancer centres, giving patients access to treatments through clinical trials. This support drives global significant advancements in blood cancer, impacting those affected by the disease.

Donation summary

Total raised
£2,608.72
+ £626.25 Gift Aid
Online donations
£2,608.72
Offline donations
£0.00

* Charities pay a small fee for our service. Find out how much it is and what we do for it.